Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB25FCMZM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,503
Award facts
- Contract value 100% obligated
- $18,502.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,502.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 unit vials. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a continuation of the company's extensive pharmaceutical supply relationship with DLA. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete openly in the federal marketplace while leveraging its woman-owned small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499.999 billion through November 2026. This overarching IDC enables DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables to support military healthcare facilities nationwide. DMS Pharmaceutical Group's established position as a critical supplier in the federal pharmaceutical supply chain, combined with its track record of delivering specialized medications including oncology treatments, vaccines, and specialty injectables to Department of Defense healthcare sites, underscores its importance to the government's medical supply infrastructure.
Quick answers
Who was awarded contract SPE2DB25FCMZM?
SPE2DB25FCMZM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FCMZM worth?
The government has obligated $18,503 on SPE2DB25FCMZM.
Is contract SPE2DB25FCMZM an order under another contract?
Yes. SPE2DB25FCMZM is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMZM competed?
The extent of competition for SPE2DB25FCMZM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award